NCT05800964CompletedPhase 1
Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Jun 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 27 Apr 2023
- Start date
- 29 Sept 2023
- Lead sponsor
- Amgen Inc.
- Diseases
- Head and neck cancer, Mesothelioma, Cervical cancer, Lung cancer, Pancreatic cancer, Metastatic breast cancer, Ovarian cancer
- NCT number
- NCT05800964
- EU CT number
- 2022-502867-39-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 58
- 9 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Technische Universität Dresden Coordinator of this site? Confirm its status | Dresden | Germany | Completed |
| Universitaetsklinikum Essen (AoR) Coordinator of this site? Confirm its status | Essen | Germany | Completed |
| Universitaetsklinikum Wuerzburg AöR Coordinator of this site? Confirm its status | Wuerzburg | Germany | Completed |
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital Clinic de Barcelona Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital Universitario 12 de Octubre Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Hospital Universitario HM Sanchinarro Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Institut Claudius Regaud Coordinator of this site? Confirm its status | Toulouse | France | Completed |
| Institut Gustave Roussy Coordinator of this site? Confirm its status | Villejuif | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.